Source: GlobalNewswire

Press Release: Kirby McInerney : Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Invivyd, Inc. (IVVD) Investors and Encourages Investors to Contact the Firm Before April 3, 2023

NEW YORK, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. ("Invivyd" or the "Company") (NASDAQ: IVVD) securities during the period from November 29, 2021 through December 14, 2021 (the "Class Period"). Investors have until April 3, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Daniel Hume's photo - Managing Partner of Kirby McInerney

Managing Partner

Daniel Hume

CEO Approval Rating

- -/100